The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells.

Autor: Durán-Prado, M1, Gahete, M D1, Hergueta-Redondo, M2, Martínez-Fuentes, A J1, Córdoba-Chacón, J1, Palacios, J3, Gracia-Navarro, F1, Moreno-Bueno, G2, Malagón, M M1, Luque, R M1, Castaño, J P1
Zdroj: Oncogene. 4/19/2012, Vol. 31 Issue 16, p2049-2061. 13p. 1 Chart, 6 Graphs.
Databáze: Academic Search Ultimate